Dopamine D2 antagonist-induced striatal Nur77 expression requires activation of mGlu5 receptors by cortical afferents

Frontiers in Pharmacology

Volumn 3 AUG, Issue , 2012, Pages

  Maheux, Jérôme ^a   St Hilaire, Michel ^b   Voyer, David ^a   Tirotta, Emanuele ^c   Borrelli, Emiliana ^c   Rouillard, Claude ^b   Rompré, Pierre Paul ^a   Lévesque, Daniel ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adenosine receptors; Antipsychotic drugs; Glutamate receptors; Neuroleptics; Nr4a 1; Organotypic culture; Striatum; Transcription factor

Indexed keywords

ADENOSINE A2A RECEPTOR; DOPAMINE 2 RECEPTOR; ETICLOPRIDE; MESSENGER RNA; METABOTROPIC RECEPTOR 5; NUCLEAR RECEPTOR NUR77;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RECEPTOR BLOCKING; DRUG MECHANISM; GENE EXPRESSION; GENETIC TRANSCRIPTION; MALE; MOUSE; NONHUMAN; NUCLEAR RECEPTOR NUR77 GENE; NUCLEOTIDE SEQUENCE; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; RECEPTOR UPREGULATION; TRANSCRIPTION REGULATION;

EID: 84866183541     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2012.00153     Document Type: Article

References (72)

1. Alcantara, A. A., Mrzljak, L., Jakab, R. L., Levey, A. I., Hersch, S. M., and Goldman-Rakic, P. S. (2001). Mus-carinic m1 and m2 receptor proteins in local circuit and projection neurons of the primate striatum: anatomical evidence for choliner-gic modulation of glutamatergic prefronto-striatal pathways. J. Comp. Neurol. 434, 445-460.
2. Bäckman, C., and Morales, M. (2002). Acute methamphetamine administration upregulates NGFI-B mRNA expression in the striatum: co-localization with C-FOS immunore-activity. Synapse 44, 158-165.
3. Bamford, N. S., Zhang, H., Schmitz, Y., Wu, N.-P., Cepeda, C., Levine, M. S., Schmauss, C., Zakharenko, S. S., Zablow, L., and Sulzer, D. (2004). Heterosynaptic dopamine neurotransmission selects sets of corticostriatal terminals. Neuron 42, 653-663.
4. Bardgett, M. E., Wrona, C. T., Newcomer, J. W., and Csernansky, J. G. (1993). Subcortical excitatory amino acid levels after acute and subchronic administration of typical and atypical neuroleptics. Eur. J. Pharmacol. 230,245-250.
5. Beaudry, G., Langlois, M.-C., Weppe, I., Rouillard, C., and Lévesque, D. (2000). Contrasting patterns and cellular specificity of transcriptional regulation of the nuclear receptor nerve growth factor-inducible B by haloperidol and clozapine in the rat forebrain. J. Neurochem. 75, 1694-1702.
6. Bello, E. P., Mateo, Y., Gelman, D. M., Noain, D., Shin, J. H., Low, M. J., Alvarez, V. A., Lovinger, D. M., and Rubinstein, M. (2011). Cocaine supersensitivity and enhanced motivation for reward in mice lacking dopamine D2 autoreceptors. Nat. Neurosci. 14, 1033-1038.
7. Bertran-Gonzalez, J., Hakansson, K., Borgkvist, A., Irinopoulou, T., Brami-Cherrier, K., Usiello, A., Greengard, P., Hervé, D., Girault, J. A.,Valjent,E.,andFisone, G. (2009). Histone H3 phosphorylation is under the opposite tonic control of dopamine D2 and adenosine A2A receptors in striatopallidal neurons. Neuropsychopharmacology 34,1710-1720.
8. Beurrier, C., Bonvento, G., Kerkerian-Le Goff, L., and Gubellini, P. (2009). Role of glutamate transporters in corticostriatal synap-tic transmission. Neuroscience 158, 1608-1615.
9. Bhardwaj, S. K., Beaudry, G., Quirion, R., Lévesque, D., and Srivastava, L. K. (2003). Neonatal ventral hippocampus lesion leads to reductions in nerve growth factor inducible-B mRNA in the prefrontal cortex and increased amphetamine response in the nucleus accumbens and dorsal striatum. Neuroscience 122,669-676.
10. Bourhis, E., Maheux, J., Rouillard, C., and Lévesque, D. (2008). Extracellular signal-regulated kinases (ERK) and protein kinase C (PKC) activities are involved in the modulation of Nur77 and Nor-1 expression by dopaminergic drugs. J. Neurochem. 106, 875-888.
11. Cabello, N., Gandia, J., Bertarelli, D. C., Watanabe, M., Lluis, C., Franco, R., Ferre, S., Lujan, R., and Ciruela, F. (2009). Metabotropic glutamate type 5, dopamine D2 and adeno-sine A2A receptors form higher-order oligomers in living cells. J. Neurochem. 109, 1497-1507.
12. Centonze, D., Battista, N., Rossi, S., Mercuri, N. B., Finazzi-Agro, A., Bernardi, G., Calabresi, P., and Mac-carrone, M. (2004a). A critical interaction between dopamine D2 receptors and endocannabinoids mediates the effects of cocaine on striatal GABAergic transmission. Neuropsy-chopharmacology 29, 1488-1497.
13. Centonze, D., Gubellini, P., Usiello, A., Rossi, S., Tscherter, A., Bracci, E., Erbs, E., Tognazzi, N., Bernardi, G., Pisani, A., Calabresi, P., and Borrelli, E. (2004b). Differential contribution of dopamine D2SandD2L receptors in the modulation of glutamate and GABA transmission in the striatum. Neuroscience 129, 157-166.
14. Cepeda, C., Hurst, R. S., Altemus, K. L., Flores-Hernandez, J., Calvert, C. R., Jokel, E. S., Grandy, D. K., Low, M. J., Rubinstein, M., Ariano, M. A., and Levine, M. S. (2001). Facilitated glutamatergic transmission in the striatum of D2 dopamine receptor-deficient mice. J. Neurophysiol. 85, 659-670.
15. Chartoff, E. H., Ward, R. P., and Dorsa, D. M. (1999). Role of adenosine and N-methyl-d-aspartate receptors in mediating haloperidol-induced gene expression and catalepsy. J. Pharmacol Exp. Ther. 291,531-537.
16. Choe, E. S., Chung, K. T., Mao, L., and Wang, J. Q. (2002). Amphetamine increases phosphorylation of extracellular signal-regulated kinase and transcription factors in the rat striatum via group I metabotropic glutamate receptors. Neuropsychophar-macology 27, 565-575.
17. Clements, R. L., and Greenshaw, A. J. (2005). Facilitation of brain stimulation reward by MK-801 (dizocilpine) maybe independent of D2-like dopamine receptor stimulation in rats. Psychopharmacology (Berl.) 182,65-74.
18. Conn, P. J., Lindsley, C. W., and Jones, C. K. (2009). Activation of metabotropic glutamate receptors as a novel approach for the treatment of schizophrenia. Trends Pharmacol. Sci. 30,25-31.
19. Corbillé, A. G., Valjent, E., Marsicano, G., Ledent, C., Lutz, B., Hervé, D., and Girault, J. A. (2007). Role of cannabinoid type 1 receptors in locomotor activity and striatal signaling in response to psychostimu-lants. J. Neurosci. 27, 6937-6947.
20. Cromwell, H. C., and Levine, M. S. (1996). Neocortical damage alters synaptic responses of neostriatal neurons in vitro. Neuroscience 75, 361-372.
21. Ethier, I., Beaudry, G., St-Hilaire, M., Milbrandt, J., Rouillard, C., and Lévesque, D. (2004a). The transcription factor NGFI-B (Nur77) and retinoids play a critical role in acute neuroleptic-induced extrapyrami-dal effect and striatal neuropeptide gene expression. Neuropsychophar-macology 29, 335-346.
22. Ethier, I., Kagechika, H., Shudo, K., Rouillard, C., and Lévesque, D. (2004b). Docosahexaenoic acid reduces haloperidol-induced dysk-inesias in mice: involvement of Nur77 and retinoid receptors. Biol. Psychiatry 56, 522-526.
23. Ferré, S., Karcz-Kubicha, M., Hope, B. T., Popoli, P., Burgueno, J., Gutierrez, M. A., Casado, V., Fuxe, K., Goldberg, S. R., Lluis, C., Franco, R., and Ciruela, F. (2002). Synergistic interaction between adenosine A2A and glutamate mGlu5 receptors: implications for striatal neuronal function. Proc. Natl. Acad. Sci. U.S.A. 99, 11940-11945.
24. Garcia, B. G., Neely, M. D., and Deutch, A. Y. (2010). Cortical regulation of striatal medium spiny neuron dendritic remodeling in parkinsonism: modulation of glutamate release reverses dopamine depletion-induced dendritic spine loss. Cereb. Cortex 20, 2423-2432.
25. Gerdeman, G., and Lovinger, D. M. (2001). CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum. J. Neurophysiol. 85, 468-471.
26. Gerfen, C. R., and Surmeier, D. J. (2011). Modulation of striatal projection systems by dopamine. Annu. Rev. Neurosci. 34,441-466.
27. Giros, B., Sokoloff, P., Martres, M.-R, Riou, J.-F., Emorine, L. J., and Schwartz, J.-C. (1989). Alternative splicing directs the expression of two D2 dopamine receptor isoforms. Nature 342, 923-926.
28. Guo, N., Robertson, G. S., and Fibiger, H. C. (1992). Scopolamine attenuates haloperidol-induced c-fos expression in the striatum. Brain Res. 588, 164-167.
29. Hattori, Y., Watanabe, M., Iwabe, T., Tanaka, E., Nishi, M., Aoyama, J., Satoda, T., Uchida, T., and Tanne, K. (2004). Administration of MK-801 decreases c-Fos expression in the trigeminal sensory nuclear complex but increases it in the midbrain during experimental movement of rat molars. Brain Res. 1021,183-191.
30. Herdegen, T., and Leah, J. D. (1998). Inducible and constitutive transcription factors in the mammalian nervous system: control of gene expression by Jun, Fos and Krox, and CREB/ATF proteins. Brain Res. Brain Res. Rev. 28, 370-490.
31. Herrera, D. G., and Robertson, H. A. (1996). Activation of c-fos in the brain. Prog. Neurobiol. 50, 83-107.
32. Higley, M. J., and Sabatini, B. L. (2010). Competitive regulation of synaptic Ca2+ influx by D2 dopamine and A2A adenosine receptors. Nat. Neurosci. 13, 958-966.
33. Higley, M. J., Soler-Llavina, G. J., and Sabatini, B. L. (2009). Cholinergic modulation of multivesicular release regulates striatal synaptic potency and integration. Nat. Neurosci. 12, 1121-1128.
34. Kachroo, A., Orlando, L. R., Grandy, D. K., Chen, J. F., Young, A. B., and Schwarzschild, M. A. (2005). Interactions between metabotropic glutamate 5 and adenosine A2A receptors in normal and parkinsonian mice. J. Neurosci. 25, 10414-10419.
35. Keefe, K. A., and Adams, A. C. (1998). Differential effects of N-methyl-d-aspartate receptor blockade on eticlopride-induced immediate early gene expression in the medial and lateral striatum. J. Pharmacol. Exp. Ther. 287, 1076-1083.
36. Khan, Z. U., Gutierrez, A., Martin, R., Penafiel, A., Rivera, A., and De La Calle, A. (1998a). Differential regional and cellular distribution of dopamine D2-like receptors: an immunocytochemical study of subtype-specific antibodies in rat and human brain. J. Comp. Neurol. 402,353-371.
37. Khan, Z. U., Mrzljak, L., Gutierrez, A., De La Calle, A., and Goldman-Rakic, P. S. (1998b). Prominence of the dopamine D2 short isoform in dopaminergic pathways. Proc. Natl. Acad. Sci. U.S.A. 95, 7731-7736.
38. Kofalvi, A., Rodrigues, R. J., Ledent, C., Mackie, K., Vizi, E. S., Cunha, R. A., and Sperlagh, B. (2005). Involvement of cannabinoid receptors in the regulation of neurotrans-mitter release in the rodent striatum: a combined immunochemi-cal and pharmacological analysis. J. Neurosci. 25, 2874-2884.
39. Krystal, J. H., Mathew, S. J., D'souza, D.C., Garakani, A., Gunduz-Bruce, H., and Charney, D. S. (2010). Potential psychiatric applications of metabotropic glutamate receptor agonists and antagonists. CNS Drugs 24, 669-693.
40. Lara, D. R., Dall'igna, O. P., Ghisolfi, E.S., and Brunstein, M. G. (2006). Involvement of adenosine in the neurobiology of schizophrenia and its therapeutic implications. Prog. Neuropsychopharmacol. Biol. Psychi atry 30,617-629.
41. Lévesque, D., and Rouillard, C. (2007). Nur77 and retinoid X receptors: crucial factors in dopamine-related neuroadaptation. Trends Neurosci. 30,22-30.
42. Lindecke, A., Korte, M., Zagrebel-sky, M., Horejschi, V., Elvers, M., Widera, D., Prullage, M., Pfeiffer, J., Kaltschmidt, B., and Kaltschmidt, C. (2006). Long-term depression activates transcription of immediate early transcription factor genes: involvement of serum response factor/Elk-1. Eur. J. Neurosci. 24, 555-563.
43. Lindgren, N., Usiello, A., Goiny, M., Haycock, J., Erbs, E., Greengard, P., Hökfelt, T., Borrelli, E., and Fisone, G. (2003). Distinct roles of dopamine D2L and D2S receptor isoforms in the regulation of protein phosphorylation at presynaptic and postsynaptic sites. Proc. Natl. Acad. Sci. U.S.A. 100,4305-4309.
44. Maheux, J., Ethier, I., Rouillard, C., and Lévesque, D. (2005). Induction patterns of transcription factors of the Nur family (Nurr1, Nur77 and Nor-1) by typical and atypical antipsychotics in the mouse brain: implication for their mechanism of action.J. Pharmacol. Exp. Ther. 313, 460-473.
45. Martelle, J. L., and Nader, M. A. (2008). A review of the discovery, pharmacological characterization, and behavioral effects of the dopamine D2-like receptor antagonist eticlopride. CNS Neurosci. Ther. 14, 248-262.
46. Martres, M.-P., Bouthenet, M.-L., Sokoloff, P., and Schwartz, J.-C. (1985). Widespread distribution of brain dopamine receptors evidenced with [125I]iodosulpride, a highly selective ligand. Science 228, 752-755.
47. Maura, G., Giardi, A., and Raiteri, M. (1988). Release-regulating D-2 dopamine receptors are located on striatal glutamatergic nerve terminals. J. Pharmacol. Exp. Ther. 247, 680-684.
48. Miyamoto, S., Duncan, G. E., Marx, C. E., and Lieberman, J. A. (2005). Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsy-chotic drugs. Mol. Psychiatry 10, 79-104.
49. Nishi, A., Liu, F., Matsuyama, S., Hamada, M., Higashi, H., Nairn, A. C., and Greengard, P. (2003). Metabotropic mGlu5 receptors regulate adenosine A2A receptor signaling. Proc. Natl. Acad. Sci. U.S.A. 100, 1322-1327.
50. Ossowska, K., Konieczny, J., Wolfarth, S., Wieronska, J., and Pilc, A. (2001). Blockade of the metabotropic gluta-mate receptor subtype 5 (mGluR5) produces antiparkinsonian-like effects in rats. Neuropharmacology 41,413-420.
51. Parelkar, N. K., and Wang, J. Q. (2004). mGluR5-dependent increases in immediate early gene expression in the rat striatum following acute administration of amphetamine. Brain Res. Mol. Brain Res. 122, 151-157.
52. Pinna, A., Wardas, J., Cozzolino, A., and Morelli, M. (1999). Involvement of adenosine A2A receptors in the induction of c-fos expression by clozapine and haloperidol. Neu-ropsychopharmacology 20, 44-51.
53. Pollack, A. E., and Fink, J. S. (1995). Adenosine antagonists potentiate D2 dopamine-dependent activation of Fos in the striatopallidal pathway. Neuroscience 68, 721-728.
54. Pozzi, L., Hakansson, K., Usiello, A., Borgkvist, A., Lindskog, M., Greengard, P., and Fisone, G. (2003). Opposite regulation by typical and atypical anti-psychotics of ERK1/2, CREB and Elk-1 phosphorylation in mouse dorsal striatum. J. Neu-rochem. 86,451-459.
55. Robertson, G. S., Lee, C. J., Sridhar, K., Nakabeppu, Y., Cheng, M., Wang, Y.-M., and Caron, M. G. (2004). Clozapine-, but not haloperidol-, induced increases in Δ FosB-like immunoreactivity are completely blocked in the striatum of mice lacking D3 dopamine receptors. Eur. J. Neurosci. 20,3189-3194.
56. Rouillard, C., Chiodo, L. A., and Freeman, A. S. (1990). The effects of the phencyclidine analogs BTCP and TCP on nigrostriatal dopamine neu-ronal activity. Eur. J. Pharmacol. 182, 227-235.
57. Rubino, T., Sala, M., Vigano, D., Braida, D., Castiglioni, C., Limonta, V., Guidali, C., Realini, N., and Paro-laro, D. (2007). Cellular mechanisms underlying the anxiolytic effect of low doses of peripheral Δ 9-tetrahydrocannabinol in rats. Neuropsychopharmacology 32, 2036-2045.
58. Schwarcz, R., Creese, I., Coyle, J. T., and Snyder, S. H. (1978). Dopamine receptors localised on cerebral cortical afferents to rat corpus striatum. Nature 271, 766-768.
59. Stahl, K., Skare, O., and Torp, R. (2009). Organotypic cultures as a model of Parkinson's disease. A twist to an old model. ScientificWorldJournal 9, 811-821.
60. St-Hilaire, M., Landry, É., Lévesque, D., and Rouillard, C. (2003). Denerva-tion and repeated L-DOPA induce a coordinate expression of the transcription factor NGFI-B in stri-atal projection pathways in hemi-Parkinsonian rats. Neurobiol Dis. 14, 98-109.
61. Stoppini, L., Buchs, P. A., and Muller, D. (1991). A simple method for organotypic cultures of nervous tissue. J. Neurosci. Methods 37, 173-182.
62. Tozzi, A., De Iure, A., Di Filippo, M., Tantucci, M., Costa, C., Borsini, F., Ghiglieri, V., Giampa, C., Fusco, E R., Picconi, B., and Calabresi, P. (2011). The distinct role of medium spiny neurons and cholinergic interneu-rons in the D2/A2A receptor interaction in the striatum: implications for Parkinson's disease. J. Neurosci. 31,1850-1862.
63. Tremblay, M., Rouillard, C., and Lévesque, D. (1999). Dopamine D3 receptor antisense administration reduces basal c-fos and NGFI-B mRNA levels in the rat forebrain. Synapse 32, 51-57.
64. Usiello, A., Baik, J. H., Rougé-Pont, F., Picetti, R., Dierich, A., Lemeur, M., Piazza, P. V., and Borrelli, E. (2000). Distinct functions of the two iso-forms of dopamine D2 receptors. Nature 408,199-203.
65. Voorn, P., Vanderschuren, L. J. M. J., Groenewegen, H. J., Robbins, T. W., and Pennartz, C. M. A. (2004). Putting a spin on the dorsal-ventral divide of the striatum. Trends Neurosci. 27, 468-474.
66. Wang, H., and Pickel, V. M. (2002). Dopamine D2 receptors are present in prefrontal cortical afferents and their targets in patches of the rat caudate-putamen nucleus. J. Comp. Neurol. 442, 392-404.
67. Wang, J. Q., and McGinty, I. E (1996). Scopolamine augments c-fos and Zif/268 messenger RNA expression induced by the full D1 dopamine receptor agonist SKF-82958 in the intact rat striatum. Neuroscience 72, 601-616.
68. Werme, M., Ringholm, A., Olson, L., and Brené, S. (2000). Differential patterns of induction of NGFI-B, Nor1 and c-fos mRNAs in striatal subre-gions by haloperidol and clozapine. Brain Res. 863, 112-119.
69. Xi, Z. X., Gilbert, J. G., Peng, X. Q., Pak, A. C., Li, X., and Gardner, E. L. (2006). Cannabinoid CB1 receptor antagonist AM251 inhibits cocaine-primed relapse in rats: role of glutamate in the nucleus accumbens. J. Neurosci. 26, 8531-8536.
70. Yamamoto, B. K., and Cooperman, M. A. (1994). Differential effects of chronic antipsychotic drug treatment on extracellular glutamate and dopamine concentrations. J. Neurosci. 14,4159-4166.
71. 2+currents in rat neostriatal cholinergic interneurons through a membrane-delimited, protein-kinase-C-insensitive pathway. J. Neurophysiol. 77,1003-1015.
72. Yin, H. H., and Lovinger, D. M. (2006). Frequency-specific and D2 receptor-mediated inhibition of glutamate release by retrograde endocannabinoid signaling. Proc. Natl. Acad. Sci. U.S.A. 103, 8251-8256.